skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
15361701
Filing Dt:
11/28/2016
Publication #:
Pub Dt:
05/18/2017
Inventor:
Daewoong JO
Title:
CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
Assignment: 1
Reel/Frame:
040690/0568Recorded: 11/28/2016Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Exec Dt:
11/25/2016
Assignees:
2319 TINNEY PLACE
BRENTWOOD, TENNESSEE 37207
9TH FLOOR, 189 SUNGAM-RO, MAPO-GU
SEOUL, KOREA, REPUBLIC OF 03929
Correspondent:
SUGHRUE MION, PLLC
2100 PENNSYLVANIA AVENUE NW, SUITE 800
WASHINGTON, DC 20037
Assignment: 2
Reel/Frame:
041061/0842Recorded: 01/24/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/23/2017
Assignee:
9TH FLOOR, 189 SUNGAM-RO, MAPO-GU
SEOUL, KOREA, REPUBLIC OF 03929
Correspondent:
SUGHRUE MION PLLC
2100 PENNSYLVANIA AVENUE, N.W.
SUITE 800
WASHINGTON, DC 20037-3213
Assignment: 3
Reel/Frame:
041685/0876Recorded: 03/22/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/08/2017
Assignee:
9TH FLOOR, 189 SUNGAM-RO, MAPO-GU
SEOUL, KOREA, REPUBLIC OF 03929
Correspondent:
SUGHRUE MION PLLC
2100 PENNSYLVANIA AVENUE, N.W.
SUITE 800
WASHINGTON, DC 20037-3213

Search Results as of: 05/10/2024 01:02 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT